Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

This session highlights practical applications of AI in optimizing antibody sequence prediction, streamlining candidate selection, and managing complex datasets in R&D workflows. Gain insights into ...

First, let’s take a look at the private biotech investments in April 2025, breaking them down by value, location, funding type, and therapeutic subsector. April 2025 saw Biohaven announce that it had ...